NeuroSense Therapeutics Ltd. (NRSN) Deferred Tax Assets, State Taxes

NeuroSense Therapeutics Ltd. Deferred Tax Assets, State Taxes

NeuroSense Therapeutics Ltd. (NRSN) had Deferred Tax Assets, State Taxes of $54.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-31.

Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsStateTaxes · last filed 2026-03-31

• 2025-12-31: Deferred Tax Assets, State Taxes $54.00K.
• 2024-12-31: Deferred Tax Assets, State Taxes $95.00K.
• 2023-12-31: Deferred Tax Assets, State Taxes $71.00K.